http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106117173-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate | 2016-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106117173-B |
| titleOfInvention | A kind of breviscapine B aglycone derivative and preparation method thereof, preparation and application |
| abstract | The invention discloses a kind of breviscapine B aglycone derivative and preparation method thereof, preparation and application, described breviscapine B aglycone derivative has following structures： Wherein, R is the compounds residues with bioactivity.Preparation method is simple and easy, and favorable reproducibility, environmental pollution is small, a large amount of preparations available for breviscapine B aglycone derivative of the present invention.Breviscapine B aglycone derivative of the present invention is the compound of brand new, with obvious blood coagulation resisting function, potential lead compound is used as, is used in the medicine for preparing treatment DVT and pulmonary thromboembolism, cardiovascular and cerebrovascular disease, apoplexy and other diseases related to blood coagulation. |
| priorityDate | 2016-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.